Disease-modifying drug reduces brain protein plaques in Alzheimer patients March 1, 2010Dr. Barry Dworkin Madely Health Headlines Commentary for March 1, 2010 [display_podcast] Source: Neuroimaging technique shows potential of bapineuzumab treatment and might be useful in assessing other drugs for Alzheimer’s Disease Reference: 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer’s disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study Related posts: Basic science research trying to unravel the mechanism of Alzheimer's disease New cell treatment may help treat MS and Cerebral Palsy Chip technology may help monitor cancer treatment success Genetic switch discovered that may help in development in treatment of stroke, heart disease, and cancer among others alzheimer'samyloidPET